KNOREX Ltd. filed a Form 6-K on November 13, 2026, disclosing that NYSE American LLC notified the company on November 11, 2026 that it has suspended trading in the company's Class A ordinary shares and commenced proceedings to delist them, citing Section 1003(f)(v) of the NYSE American Company Guide based on the low selling price of the shares.

Key Highlights

  • Trading suspended immediately: NYSE American suspended trading in KNOREX Ltd.'s Class A ordinary shares effective immediately on November 11, 2026.
  • Delisting basis: The Exchange cited Section 1003(f)(v) of the NYSE American Company Guide, based on the low selling price of the Class A ordinary shares.
  • Appeal deadline: According to the filing, the company must request a review by no later than November 18, 2026.
  • Company intends to appeal: KNOREX Ltd. disclosed it intends to appeal by requesting a hearing before a Listings Qualifications Panel of the Committee for Review of the Board of Directors of the Exchange, as permitted under Section 1203 of the NYSE American Company Guide.
  • Reverse stock split considered: The company disclosed it "currently intends to seek to effect a reverse stock split as a tool to support its appeal and continued listing."
  • Shares remain listed during appeal: The filing states the Class A ordinary shares remain listed on NYSE American while the appeal is pending, though trading remains suspended.

KNOREX Ltd. Receives NYSE American Delisting Notice Citing Low Share Price

According to the Form 6-K filed with the U.S. Securities and Exchange Commission, KNOREX Ltd. (NYSE American:KNRX) received formal notification on November 11, 2026 from NYSE American LLC that the exchange had suspended trading in the company's Class A ordinary shares effective immediately and had determined to commence delisting proceedings. The exchange cited Section 1003(f)(v) of the NYSE American Company Guide, with the low selling price of the Class A ordinary shares identified as the basis for the determination.

The filing states that NYSE American publicly announced its decision on November 11, 2026, and that the exchange "will apply to the U.S. Securities and Exchange Commission to delist the ordinary shares only upon completion of all applicable procedures, including any appeal by the Company." The company disclosed it intends to appeal the staff's determination by requesting a hearing before a Listings Qualifications Panel, as permitted under Section 1203 of the NYSE American Company Guide, and that the deadline for requesting such a review is no later than November 18, 2026.

As part of its appeal strategy, the company disclosed it "currently intends to seek to effect a reverse stock split as a tool to support its appeal and continued listing," while noting that "a reverse stock split would not, by itself, change shareholders' percentage ownership of the Company." The filing also includes a cautionary statement that "there can be no assurance, however, that the Panel will grant the Company's request for continued listing, or that the Company will be able to regain compliance with the continued listing standards of NYSE American." The report contains forward-looking statements which the company characterizes as subject to risks and uncertainties that could cause actual results to differ materially.

What Was Disclosed

KNOREX Ltd. disclosed receipt of a delisting notice from NYSE American LLC citing low share price under Section 1003(f)(v) of the NYSE American Company Guide, an immediate trading suspension, the company's intent to appeal, and plans to explore a reverse stock split in connection with that appeal.